amendment #4 to the amended and restated senior secured promissory note originally issued on september 28, 2018Senior Secured Promissory Note • July 20th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies
THIS AMENDMENT #4 to the Note (as defined below) (the “Amendment”) is entered into effective July 15, 2020 (the “Effective Date”), by and between Predictive Oncology, Inc. (f/k/a Precision Therapeutics, Inc.), a Delaware corporation (the “Company”), and L2 Capital, LLC, a Kansas limited liability company (the “Holder”, and together with the Company, the “Parties”).
AMENDMENT #1 TO THE SENIOR SECURED PROMISSORY NOTE ORIGINALLY ISSUED ON FEBRUARY 5, 2020Senior Secured Promissory Note Amendment • July 20th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies
THIS AMENDMENT #1 to the Note (as defined below) (the "Amendment") is entered into effective July 15, 2020 (the "Effective Date"), by and between Predictive Oncology, Inc. (a/k/a Precision Therapeutics, Inc.), a Delaware corporation (the "Company"), and Oasis Capital, LLC, a Puerto Rico limited liability company (the "Holder", and together with the Company, the "Parties").
AMENDMENT #2 TO THE SENIOR SECURED PROMISSORY NOTE ORIGINALLY ISSUED ON SEPTEMBER 27, 2019Senior Secured Promissory Note Amendment • July 20th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies
THIS AMENDMENT #2 to the Note (as defined below) (the "Amendment") is entered into effective July 15, 2020 (the "Effective Date"), by and between Predictive Oncology, Inc. (fka Precision Therapeutics, Inc.), a Delaware corporation (the "Company"), and Oasis Capital, LLC, a Puerto Rico limited liability company (the "Holder", and together with the Company, the "Parties").
